RBC Capital Maintains Outperform on Zimmer Biomet Holdings, Raises Price Target to $140
Portfolio Pulse from Benzinga Newsdesk
RBC Capital analyst Shagun Singh has maintained an Outperform rating on Zimmer Biomet Holdings (NYSE:ZBH) and increased the price target from $134 to $140.
January 12, 2024 | 7:48 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
RBC Capital analyst Shagun Singh reaffirmed an Outperform rating on Zimmer Biomet Holdings and raised the price target from $134 to $140.
The increase in price target by RBC Capital suggests a positive outlook on the company's future performance, which could lead to increased investor confidence and a potential rise in the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100